| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bipolar Disorder | 214 | 2024 | 387 | 18.210 |
Why?
|
| Psychotic Disorders | 74 | 2024 | 195 | 9.320 |
Why?
|
| Schizophrenia | 108 | 2024 | 483 | 9.220 |
Why?
|
| Genetic Linkage | 80 | 2014 | 624 | 3.960 |
Why?
|
| Genetic Predisposition to Disease | 68 | 2024 | 2340 | 3.320 |
Why?
|
| Genome-Wide Association Study | 40 | 2024 | 1671 | 2.770 |
Why?
|
| Polymorphism, Single Nucleotide | 52 | 2024 | 2401 | 2.200 |
Why?
|
| Mental Disorders | 26 | 2018 | 414 | 2.110 |
Why?
|
| Genetic Markers | 51 | 2016 | 478 | 1.690 |
Why?
|
| Chromosome Mapping | 42 | 2012 | 1076 | 1.350 |
Why?
|
| Humans | 352 | 2024 | 89357 | 1.320 |
Why?
|
| Brain | 28 | 2024 | 2285 | 1.320 |
Why?
|
| Family | 21 | 2021 | 325 | 1.280 |
Why?
|
| Pedigree | 64 | 2015 | 970 | 1.150 |
Why?
|
| Lithium | 21 | 2023 | 59 | 1.080 |
Why?
|
| Genotype | 47 | 2020 | 1849 | 1.060 |
Why?
|
| Mood Disorders | 17 | 2011 | 81 | 1.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 10 | 2017 | 51 | 1.020 |
Why?
|
| Genetic Testing | 4 | 2015 | 537 | 0.990 |
Why?
|
| Genome, Human | 20 | 2021 | 767 | 0.960 |
Why?
|
| Genetic Variation | 13 | 2018 | 1374 | 0.960 |
Why?
|
| Schizophrenic Psychology | 9 | 2018 | 133 | 0.920 |
Why?
|
| Family Health | 13 | 2013 | 162 | 0.900 |
Why?
|
| Genetic Counseling | 4 | 2013 | 101 | 0.900 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 499 | 0.840 |
Why?
|
| Male | 180 | 2024 | 42411 | 0.830 |
Why?
|
| Depressive Disorder | 28 | 1997 | 221 | 0.810 |
Why?
|
| Female | 188 | 2024 | 46202 | 0.790 |
Why?
|
| Cognitive Dysfunction | 5 | 2022 | 146 | 0.780 |
Why?
|
| Phenotype | 35 | 2024 | 2440 | 0.770 |
Why?
|
| Affective Disorders, Psychotic | 11 | 2019 | 16 | 0.760 |
Why?
|
| Adult | 119 | 2024 | 26607 | 0.740 |
Why?
|
| Genes | 12 | 2003 | 305 | 0.710 |
Why?
|
| Alleles | 32 | 2022 | 1135 | 0.710 |
Why?
|
| Cognition | 13 | 2023 | 580 | 0.700 |
Why?
|
| Chromosomes, Human, Pair 18 | 8 | 1999 | 42 | 0.690 |
Why?
|
| Pursuit, Smooth | 4 | 2024 | 32 | 0.690 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2019 | 15 | 0.690 |
Why?
|
| Lateral Ventricles | 1 | 2019 | 12 | 0.690 |
Why?
|
| Cognition Disorders | 6 | 2022 | 235 | 0.670 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 121 | 0.650 |
Why?
|
| Linkage Disequilibrium | 20 | 2018 | 477 | 0.590 |
Why?
|
| Polymorphism, Restriction Fragment Length | 10 | 1991 | 147 | 0.570 |
Why?
|
| Carrier Proteins | 8 | 2013 | 681 | 0.560 |
Why?
|
| Depressive Disorder, Major | 10 | 2021 | 166 | 0.550 |
Why?
|
| Genomics | 4 | 2023 | 762 | 0.550 |
Why?
|
| Executive Function | 5 | 2022 | 91 | 0.540 |
Why?
|
| X Chromosome | 17 | 1997 | 153 | 0.540 |
Why?
|
| Gene Frequency | 16 | 2024 | 685 | 0.530 |
Why?
|
| Lod Score | 28 | 2008 | 152 | 0.520 |
Why?
|
| Genetic Association Studies | 6 | 2021 | 294 | 0.510 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2024 | 3448 | 0.510 |
Why?
|
| Lithium Compounds | 6 | 2023 | 9 | 0.500 |
Why?
|
| Connectome | 3 | 2021 | 76 | 0.480 |
Why?
|
| Models, Genetic | 23 | 2010 | 945 | 0.480 |
Why?
|
| DNA Copy Number Variations | 5 | 2016 | 177 | 0.480 |
Why?
|
| Pharmacogenetics | 5 | 2023 | 443 | 0.480 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 39 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 6 | 9 | 2019 | 125 | 0.470 |
Why?
|
| Case-Control Studies | 22 | 2024 | 1862 | 0.470 |
Why?
|
| Gene Regulatory Networks | 5 | 2023 | 308 | 0.470 |
Why?
|
| Nerve Net | 5 | 2021 | 374 | 0.460 |
Why?
|
| Prefrontal Cortex | 2 | 2019 | 134 | 0.460 |
Why?
|
| Quantitative Trait Loci | 6 | 2024 | 608 | 0.450 |
Why?
|
| Genetics, Behavioral | 6 | 2004 | 22 | 0.450 |
Why?
|
| Genetic Diseases, Inborn | 7 | 1998 | 101 | 0.450 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 38 | 0.450 |
Why?
|
| Gene Expression | 5 | 2014 | 1310 | 0.450 |
Why?
|
| Behavior | 3 | 2002 | 85 | 0.440 |
Why?
|
| Middle Aged | 70 | 2024 | 25974 | 0.440 |
Why?
|
| Emotions | 6 | 2021 | 349 | 0.410 |
Why?
|
| Social Environment | 6 | 2007 | 187 | 0.410 |
Why?
|
| Affective Symptoms | 12 | 2019 | 50 | 0.410 |
Why?
|
| Parietal Lobe | 3 | 2019 | 119 | 0.400 |
Why?
|
| Down-Regulation | 1 | 2013 | 519 | 0.390 |
Why?
|
| Personality | 3 | 2011 | 134 | 0.380 |
Why?
|
| Mutation | 7 | 2022 | 4143 | 0.370 |
Why?
|
| Biomarkers | 8 | 2024 | 1767 | 0.370 |
Why?
|
| Multifactorial Inheritance | 5 | 2021 | 169 | 0.370 |
Why?
|
| Evoked Potentials, Auditory | 4 | 2022 | 37 | 0.370 |
Why?
|
| Haplotypes | 12 | 2018 | 637 | 0.370 |
Why?
|
| Endophenotypes | 3 | 2022 | 17 | 0.360 |
Why?
|
| Autistic Disorder | 3 | 2013 | 150 | 0.360 |
Why?
|
| Cerebellum | 7 | 2022 | 249 | 0.360 |
Why?
|
| Pattern Recognition, Visual | 3 | 2021 | 155 | 0.360 |
Why?
|
| Sequence Analysis, DNA | 7 | 2014 | 866 | 0.350 |
Why?
|
| Evoked Potentials | 5 | 2021 | 190 | 0.350 |
Why?
|
| Risk | 23 | 2019 | 657 | 0.340 |
Why?
|
| Hallucinations | 4 | 2023 | 29 | 0.330 |
Why?
|
| Risk Factors | 25 | 2021 | 5499 | 0.330 |
Why?
|
| Gray Matter | 2 | 2019 | 35 | 0.330 |
Why?
|
| Fibroblasts | 7 | 2023 | 755 | 0.330 |
Why?
|
| Suicide, Attempted | 7 | 2011 | 133 | 0.320 |
Why?
|
| Saccades | 5 | 2022 | 69 | 0.310 |
Why?
|
| Adolescent | 32 | 2024 | 9263 | 0.310 |
Why?
|
| Young Adult | 16 | 2024 | 6312 | 0.310 |
Why?
|
| Genetic Loci | 3 | 2019 | 253 | 0.300 |
Why?
|
| Monoamine Oxidase | 10 | 2005 | 25 | 0.300 |
Why?
|
| Frontal Lobe | 2 | 2018 | 132 | 0.300 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 401 | 0.300 |
Why?
|
| Genetics | 2 | 2004 | 24 | 0.290 |
Why?
|
| Polymorphism, Genetic | 14 | 2004 | 825 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 7 | 2010 | 511 | 0.290 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 1988 | 73 | 0.280 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 726 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 1997 | 54 | 0.280 |
Why?
|
| Circadian Rhythm | 4 | 2023 | 305 | 0.280 |
Why?
|
| Antimanic Agents | 3 | 2023 | 13 | 0.270 |
Why?
|
| Blood Platelets | 11 | 1986 | 150 | 0.270 |
Why?
|
| Chromosomes, Human, X | 3 | 2016 | 55 | 0.270 |
Why?
|
| Neurotransmitter Agents | 5 | 2008 | 108 | 0.260 |
Why?
|
| Suicide | 3 | 2007 | 151 | 0.260 |
Why?
|
| Software | 7 | 2011 | 665 | 0.260 |
Why?
|
| Oxytocin | 2 | 2018 | 73 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2011 | 79 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 22 | 5 | 2012 | 44 | 0.250 |
Why?
|
| Age of Onset | 7 | 2021 | 312 | 0.250 |
Why?
|
| Calcium Channels | 3 | 2023 | 182 | 0.250 |
Why?
|
| Whole Genome Sequencing | 2 | 2022 | 87 | 0.250 |
Why?
|
| Electroencephalography | 6 | 2022 | 751 | 0.250 |
Why?
|
| Neurons | 5 | 2023 | 1584 | 0.250 |
Why?
|
| Antipsychotic Agents | 3 | 2024 | 131 | 0.250 |
Why?
|
| Neural Stem Cells | 2 | 2023 | 58 | 0.250 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 87 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 2 | 5 | 2007 | 85 | 0.230 |
Why?
|
| Temporal Lobe | 2 | 2018 | 176 | 0.230 |
Why?
|
| Neural Pathways | 3 | 2021 | 319 | 0.230 |
Why?
|
| Psychiatric Status Rating Scales | 14 | 2018 | 492 | 0.230 |
Why?
|
| Disclosure | 1 | 2004 | 110 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 20 | 4 | 2008 | 32 | 0.230 |
Why?
|
| Psychomotor Performance | 3 | 2022 | 496 | 0.220 |
Why?
|
| Social Perception | 2 | 2014 | 95 | 0.220 |
Why?
|
| HLA Antigens | 8 | 1989 | 227 | 0.220 |
Why?
|
| Neuropsychological Tests | 6 | 2023 | 505 | 0.220 |
Why?
|
| DNA Methylation | 3 | 2014 | 657 | 0.220 |
Why?
|
| Pilot Projects | 2 | 2023 | 871 | 0.210 |
Why?
|
| INDEL Mutation | 1 | 2022 | 31 | 0.210 |
Why?
|
| Calcium Channel Blockers | 1 | 2023 | 121 | 0.210 |
Why?
|
| Gene Expression Regulation | 6 | 2018 | 1976 | 0.210 |
Why?
|
| Homosexuality, Male | 2 | 2017 | 299 | 0.210 |
Why?
|
| Molecular Sequence Data | 12 | 2014 | 3027 | 0.210 |
Why?
|
| Prospective Studies | 5 | 2021 | 4289 | 0.210 |
Why?
|
| Research | 5 | 1998 | 252 | 0.210 |
Why?
|
| Cannabis | 1 | 2023 | 35 | 0.210 |
Why?
|
| Lissencephaly | 1 | 2022 | 22 | 0.210 |
Why?
|
| Pharmacogenomic Testing | 1 | 2023 | 98 | 0.210 |
Why?
|
| Vasopressins | 2 | 2018 | 50 | 0.210 |
Why?
|
| Focal Adhesions | 1 | 2023 | 70 | 0.210 |
Why?
|
| Gene Expression Profiling | 5 | 2023 | 1431 | 0.200 |
Why?
|
| Milk | 2 | 2020 | 53 | 0.200 |
Why?
|
| Circadian Clocks | 1 | 2023 | 62 | 0.200 |
Why?
|
| Cattle | 2 | 2020 | 375 | 0.200 |
Why?
|
| Facial Recognition | 1 | 2021 | 16 | 0.200 |
Why?
|
| Neuroimaging | 2 | 2019 | 117 | 0.200 |
Why?
|
| Methamphetamine | 1 | 2023 | 85 | 0.200 |
Why?
|
| Nuclear Family | 12 | 2013 | 93 | 0.200 |
Why?
|
| Auditory Pathways | 1 | 2021 | 33 | 0.190 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2021 | 17 | 0.190 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 1986 | 85 | 0.190 |
Why?
|
| Cholinergic Antagonists | 2 | 2021 | 27 | 0.190 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 54 | 0.190 |
Why?
|
| Sample Size | 2 | 2020 | 128 | 0.190 |
Why?
|
| Molecular Biology | 1 | 2002 | 89 | 0.190 |
Why?
|
| Cattle Diseases | 1 | 2020 | 6 | 0.190 |
Why?
|
| Heat Stress Disorders | 1 | 2020 | 12 | 0.190 |
Why?
|
| Depression | 18 | 1996 | 505 | 0.190 |
Why?
|
| Child | 15 | 2023 | 7174 | 0.190 |
Why?
|
| Receptors, Dopamine D2 | 3 | 1996 | 57 | 0.190 |
Why?
|
| Primary Prevention | 1 | 2021 | 82 | 0.180 |
Why?
|
| Inflammation | 3 | 2023 | 972 | 0.180 |
Why?
|
| Arecoline | 6 | 1989 | 6 | 0.180 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 82 | 0.180 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 556 | 0.180 |
Why?
|
| Delusions | 2 | 2012 | 11 | 0.180 |
Why?
|
| White Matter | 1 | 2021 | 84 | 0.170 |
Why?
|
| Color Vision Defects | 9 | 1991 | 22 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 8 | 4 | 2014 | 85 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 1999 | 100 | 0.170 |
Why?
|
| Transcriptome | 2 | 2023 | 630 | 0.170 |
Why?
|
| Pleasure | 1 | 2019 | 14 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 59 | 0.170 |
Why?
|
| Support Vector Machine | 1 | 2019 | 25 | 0.170 |
Why?
|
| Chromosome Aberrations | 4 | 2008 | 390 | 0.170 |
Why?
|
| Choroid Plexus | 1 | 2019 | 15 | 0.170 |
Why?
|
| Receptors, Cholinergic | 3 | 2007 | 77 | 0.170 |
Why?
|
| Gamma Rhythm | 1 | 2019 | 14 | 0.170 |
Why?
|
| Beta Rhythm | 1 | 2019 | 19 | 0.160 |
Why?
|
| POU Domain Factors | 1 | 2018 | 8 | 0.160 |
Why?
|
| Genetics, Medical | 3 | 1997 | 52 | 0.160 |
Why?
|
| Visual Cortex | 1 | 2022 | 255 | 0.160 |
Why?
|
| DNA, Complementary | 3 | 2006 | 392 | 0.160 |
Why?
|
| Proteins | 3 | 2009 | 787 | 0.160 |
Why?
|
| Receptors, Adrenergic, alpha | 2 | 1991 | 16 | 0.160 |
Why?
|
| Aged | 20 | 2022 | 19165 | 0.160 |
Why?
|
| Digestion | 1 | 2018 | 8 | 0.160 |
Why?
|
| Animal Feed | 1 | 2018 | 20 | 0.160 |
Why?
|
| Sex Characteristics | 2 | 2018 | 326 | 0.160 |
Why?
|
| Receptors, Corticotropin | 2 | 1995 | 5 | 0.160 |
Why?
|
| Neurophysins | 1 | 2018 | 4 | 0.160 |
Why?
|
| Antisocial Personality Disorder | 5 | 1995 | 92 | 0.160 |
Why?
|
| Dietary Fiber | 1 | 2018 | 44 | 0.160 |
Why?
|
| Aging | 2 | 2022 | 718 | 0.160 |
Why?
|
| Statistics, Nonparametric | 9 | 2007 | 306 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 1997 | 109 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 2003 | 48 | 0.150 |
Why?
|
| Retina | 1 | 2020 | 219 | 0.150 |
Why?
|
| Clinical Medicine | 1 | 1998 | 34 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2018 | 140 | 0.150 |
Why?
|
| Microsatellite Repeats | 6 | 2012 | 148 | 0.150 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2021 | 144 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 11 | 5 | 2003 | 106 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2013 | 387 | 0.150 |
Why?
|
| Political Systems | 1 | 1997 | 1 | 0.150 |
Why?
|
| Eugenics | 1 | 1997 | 4 | 0.150 |
Why?
|
| Euthanasia | 1 | 1997 | 16 | 0.150 |
Why?
|
| Antidepressive Agents | 2 | 2016 | 111 | 0.150 |
Why?
|
| Base Sequence | 10 | 2014 | 2327 | 0.140 |
Why?
|
| Chromosomes, Human | 4 | 2021 | 66 | 0.140 |
Why?
|
| Borderline Personality Disorder | 1 | 2017 | 34 | 0.140 |
Why?
|
| Thalamus | 1 | 2018 | 134 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 1997 | 59 | 0.140 |
Why?
|
| Panic Disorder | 3 | 2003 | 21 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2018 | 186 | 0.140 |
Why?
|
| GTP-Binding Proteins | 3 | 1994 | 145 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 362 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2008 | 79 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 424 | 0.140 |
Why?
|
| Psychiatry | 1 | 1997 | 82 | 0.140 |
Why?
|
| Publishing | 1 | 1997 | 90 | 0.140 |
Why?
|
| Receptors, Drug | 3 | 1991 | 54 | 0.140 |
Why?
|
| Erythrocytes | 8 | 1982 | 254 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2014 | 432 | 0.130 |
Why?
|
| DNA | 7 | 2005 | 1308 | 0.130 |
Why?
|
| Serotonin | 3 | 2011 | 221 | 0.130 |
Why?
|
| Sex Chromosome Aberrations | 2 | 1991 | 19 | 0.130 |
Why?
|
| Diseases in Twins | 13 | 1987 | 65 | 0.130 |
Why?
|
| Catechol O-Methyltransferase | 6 | 2020 | 69 | 0.130 |
Why?
|
| Arginine Vasopressin | 2 | 2014 | 44 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2018 | 327 | 0.130 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1995 | 3 | 0.130 |
Why?
|
| Disease Susceptibility | 8 | 1998 | 200 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 1714 | 0.130 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2015 | 13 | 0.130 |
Why?
|
| Psychological Trauma | 1 | 2015 | 8 | 0.130 |
Why?
|
| Personality Inventory | 3 | 2013 | 109 | 0.120 |
Why?
|
| Receptors, Muscarinic | 5 | 1992 | 48 | 0.120 |
Why?
|
| National Institute of Mental Health (U.S.) | 9 | 2004 | 22 | 0.120 |
Why?
|
| Genes, Dominant | 4 | 1989 | 117 | 0.120 |
Why?
|
| Public Policy | 1 | 2014 | 52 | 0.120 |
Why?
|
| Neostriatum | 1 | 2014 | 26 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2014 | 695 | 0.120 |
Why?
|
| Sex Chromosomes | 7 | 1980 | 57 | 0.120 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 246 | 0.120 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 1840 | 0.120 |
Why?
|
| Cloning, Molecular | 4 | 2009 | 646 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 7 | 2008 | 922 | 0.110 |
Why?
|
| Probability | 7 | 2002 | 353 | 0.110 |
Why?
|
| Family Conflict | 1 | 2013 | 2 | 0.110 |
Why?
|
| Trinucleotide Repeats | 3 | 2000 | 32 | 0.110 |
Why?
|
| Syndactyly | 1 | 2013 | 12 | 0.110 |
Why?
|
| Gene Dosage | 3 | 2011 | 208 | 0.110 |
Why?
|
| Cerebral Cortex | 4 | 2024 | 589 | 0.110 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 112 | 0.110 |
Why?
|
| DNA, Satellite | 1 | 1993 | 19 | 0.110 |
Why?
|
| Sex Factors | 15 | 2010 | 1066 | 0.110 |
Why?
|
| Reproducibility of Results | 7 | 2018 | 2758 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2013 | 2303 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2014 | 234 | 0.110 |
Why?
|
| Twins, Monozygotic | 8 | 1984 | 57 | 0.110 |
Why?
|
| Thymine | 1 | 1993 | 17 | 0.110 |
Why?
|
| Long QT Syndrome | 1 | 2013 | 36 | 0.110 |
Why?
|
| Brain Mapping | 3 | 2023 | 564 | 0.110 |
Why?
|
| Stereotyped Behavior | 1 | 2013 | 12 | 0.110 |
Why?
|
| Signal Transduction | 4 | 2015 | 3385 | 0.110 |
Why?
|
| Genetic Techniques | 2 | 1988 | 73 | 0.110 |
Why?
|
| Social Stigma | 1 | 2013 | 63 | 0.110 |
Why?
|
| Codon | 1 | 1993 | 122 | 0.110 |
Why?
|
| Alcoholism | 10 | 2010 | 178 | 0.110 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2012 | 11 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2005 | 65 | 0.110 |
Why?
|
| Reflex, Startle | 1 | 2013 | 32 | 0.110 |
Why?
|
| Facial Expression | 3 | 2021 | 51 | 0.110 |
Why?
|
| User-Computer Interface | 2 | 2004 | 187 | 0.100 |
Why?
|
| Cytosine | 1 | 1993 | 128 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2008 | 443 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2021 | 590 | 0.100 |
Why?
|
| Odds Ratio | 5 | 2010 | 683 | 0.100 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1991 | 49 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 172 | 0.100 |
Why?
|
| Age Factors | 14 | 1992 | 1870 | 0.100 |
Why?
|
| Receptors, Cell Surface | 4 | 1993 | 289 | 0.100 |
Why?
|
| Temperament | 1 | 2011 | 27 | 0.100 |
Why?
|
| Datasets as Topic | 2 | 2022 | 75 | 0.100 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2011 | 1 | 0.100 |
Why?
|
| Saliva | 2 | 1982 | 124 | 0.100 |
Why?
|
| Marriage | 4 | 1981 | 25 | 0.100 |
Why?
|
| Genes, Duplicate | 1 | 2011 | 19 | 0.090 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 31 | 0.090 |
Why?
|
| Factor IX | 1 | 1990 | 4 | 0.090 |
Why?
|
| United States | 15 | 2015 | 6989 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 96 | 0.090 |
Why?
|
| Wnt Proteins | 2 | 2008 | 130 | 0.090 |
Why?
|
| Sequence Deletion | 2 | 2008 | 205 | 0.090 |
Why?
|
| Computer Simulation | 2 | 1996 | 1097 | 0.090 |
Why?
|
| Dextroamphetamine | 5 | 1984 | 108 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2010 | 30 | 0.090 |
Why?
|
| Databases, Genetic | 2 | 2018 | 263 | 0.090 |
Why?
|
| Hydrocortisone | 7 | 1984 | 302 | 0.090 |
Why?
|
| Animals | 13 | 2023 | 27371 | 0.090 |
Why?
|
| Likelihood Functions | 3 | 2003 | 251 | 0.090 |
Why?
|
| Motivation | 1 | 2013 | 296 | 0.090 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 17 | 0.090 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 10 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2014 | 551 | 0.090 |
Why?
|
| Exons | 5 | 2011 | 451 | 0.090 |
Why?
|
| Lactation | 2 | 2020 | 54 | 0.090 |
Why?
|
| Neuropeptides | 2 | 1987 | 114 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 127 | 0.080 |
Why?
|
| Serine Endopeptidases | 1 | 2010 | 146 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 299 | 0.080 |
Why?
|
| Herpesvirus 4, Human | 2 | 1986 | 119 | 0.080 |
Why?
|
| Mice | 7 | 2023 | 11761 | 0.080 |
Why?
|
| Brain Damage, Chronic | 2 | 1988 | 26 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2007 | 54 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 27 | 0.080 |
Why?
|
| Cells, Cultured | 7 | 2018 | 2884 | 0.080 |
Why?
|
| Hormones | 2 | 1992 | 139 | 0.080 |
Why?
|
| PPAR delta | 1 | 2008 | 2 | 0.080 |
Why?
|
| Neurocognitive Disorders | 2 | 1987 | 13 | 0.080 |
Why?
|
| Twins | 3 | 1983 | 65 | 0.080 |
Why?
|
| Adoption | 2 | 1986 | 9 | 0.080 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1985 | 15 | 0.080 |
Why?
|
| Melatonin | 1 | 1988 | 50 | 0.080 |
Why?
|
| HMGB2 Protein | 1 | 2008 | 4 | 0.080 |
Why?
|
| Age Distribution | 2 | 2021 | 200 | 0.080 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 26 | 0.080 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2008 | 9 | 0.080 |
Why?
|
| Antibodies, Viral | 2 | 1986 | 309 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1988 | 105 | 0.080 |
Why?
|
| Limbic System | 1 | 1988 | 23 | 0.080 |
Why?
|
| Depression, Postpartum | 1 | 2008 | 15 | 0.080 |
Why?
|
| Obstetric Labor Complications | 1 | 1988 | 34 | 0.070 |
Why?
|
| Lymphocytes | 2 | 1987 | 471 | 0.070 |
Why?
|
| Life Change Events | 1 | 2007 | 48 | 0.070 |
Why?
|
| Memory | 1 | 2009 | 220 | 0.070 |
Why?
|
| Sleep, REM | 5 | 1989 | 51 | 0.070 |
Why?
|
| Hippocampus | 3 | 2023 | 447 | 0.070 |
Why?
|
| Animal Welfare | 1 | 1988 | 44 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1176 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 2013 | 211 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 73 | 0.070 |
Why?
|
| Introns | 4 | 2009 | 299 | 0.070 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1988 | 111 | 0.070 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1987 | 26 | 0.070 |
Why?
|
| Capsid Proteins | 1 | 1986 | 32 | 0.070 |
Why?
|
| Dopamine | 4 | 2023 | 276 | 0.070 |
Why?
|
| Oncogenes | 1 | 1987 | 92 | 0.070 |
Why?
|
| Environment | 2 | 1987 | 223 | 0.070 |
Why?
|
| Herpesviridae Infections | 1 | 1986 | 46 | 0.070 |
Why?
|
| Self Report | 2 | 2020 | 297 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 129 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2015 | 899 | 0.070 |
Why?
|
| Genetic Heterogeneity | 4 | 2013 | 63 | 0.070 |
Why?
|
| Learning | 1 | 2009 | 285 | 0.070 |
Why?
|
| Ethanolamines | 1 | 1986 | 24 | 0.070 |
Why?
|
| Imipramine | 2 | 1984 | 16 | 0.070 |
Why?
|
| DNA, Recombinant | 2 | 1983 | 67 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 1242 | 0.070 |
Why?
|
| Ovulation | 1 | 2006 | 68 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1986 | 72 | 0.070 |
Why?
|
| Sequence Tagged Sites | 2 | 2003 | 11 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2016 | 219 | 0.070 |
Why?
|
| Gene Library | 1 | 2006 | 133 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 1986 | 78 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 1986 | 148 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1983 | 79 | 0.060 |
Why?
|
| Genetic Carrier Screening | 5 | 1991 | 60 | 0.060 |
Why?
|
| Substance P | 1 | 1985 | 61 | 0.060 |
Why?
|
| Interview, Psychological | 4 | 2017 | 69 | 0.060 |
Why?
|
| Models, Statistical | 4 | 2018 | 576 | 0.060 |
Why?
|
| Cerebral Ventriculography | 1 | 1985 | 8 | 0.060 |
Why?
|
| Herpes Simplex | 1 | 1986 | 203 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2011 | 2872 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 10 | 3 | 2000 | 47 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 1988 | 345 | 0.060 |
Why?
|
| Research Design | 6 | 2011 | 599 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2017 | 49 | 0.060 |
Why?
|
| Anxiety | 2 | 1986 | 308 | 0.060 |
Why?
|
| Kinetics | 4 | 1993 | 1528 | 0.060 |
Why?
|
| Skin | 2 | 1986 | 582 | 0.060 |
Why?
|
| DNA Primers | 2 | 2003 | 543 | 0.060 |
Why?
|
| Internet | 2 | 2004 | 319 | 0.060 |
Why?
|
| Mass Screening | 2 | 2004 | 636 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 1072 | 0.060 |
Why?
|
| Attitude | 2 | 1983 | 130 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2018 | 2017 | 0.060 |
Why?
|
| Behavior Control | 1 | 2023 | 4 | 0.060 |
Why?
|
| Cyclic AMP | 3 | 2011 | 274 | 0.060 |
Why?
|
| Thinking | 1 | 2023 | 35 | 0.060 |
Why?
|
| Anorexia Nervosa | 1 | 1984 | 142 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2624 | 0.050 |
Why?
|
| Social Control, Informal | 1 | 1983 | 5 | 0.050 |
Why?
|
| Social Control, Formal | 1 | 1983 | 12 | 0.050 |
Why?
|
| HLA-B Antigens | 1 | 1983 | 27 | 0.050 |
Why?
|
| HLA-A Antigens | 1 | 1983 | 40 | 0.050 |
Why?
|
| Salivation | 1 | 1982 | 3 | 0.050 |
Why?
|
| Pregnancy | 10 | 2008 | 3018 | 0.050 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 1997 | 44 | 0.050 |
Why?
|
| Parasympatholytics | 1 | 1982 | 19 | 0.050 |
Why?
|
| Caspases | 1 | 2023 | 155 | 0.050 |
Why?
|
| Government Regulation | 1 | 1983 | 49 | 0.050 |
Why?
|
| Ouabain | 1 | 1982 | 24 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 956 | 0.050 |
Why?
|
| Erythrocyte Membrane | 1 | 1982 | 61 | 0.050 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2022 | 1 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 46 | 0.050 |
Why?
|
| Inheritance Patterns | 2 | 2013 | 48 | 0.050 |
Why?
|
| Time Factors | 9 | 2008 | 5338 | 0.050 |
Why?
|
| CpG Islands | 2 | 2014 | 157 | 0.050 |
Why?
|
| Psychological Tests | 4 | 2014 | 91 | 0.050 |
Why?
|
| Receptors, Nicotinic | 1 | 1983 | 131 | 0.050 |
Why?
|
| Chronic Disease | 4 | 1993 | 950 | 0.050 |
Why?
|
| Psychological Techniques | 1 | 2021 | 3 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2008 | 243 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 52 | 0.050 |
Why?
|
| Presenilin-2 | 1 | 2021 | 25 | 0.050 |
Why?
|
| Culture | 1 | 2002 | 53 | 0.050 |
Why?
|
| Insulin | 1 | 1987 | 1146 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 117 | 0.050 |
Why?
|
| Models, Biological | 4 | 2009 | 1765 | 0.050 |
Why?
|
| Presenilin-1 | 1 | 2021 | 100 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 192 | 0.050 |
Why?
|
| Acoustic Stimulation | 1 | 2021 | 127 | 0.050 |
Why?
|
| Anisotropy | 1 | 2021 | 63 | 0.050 |
Why?
|
| Major Histocompatibility Complex | 1 | 2021 | 84 | 0.050 |
Why?
|
| Logistic Models | 3 | 2016 | 1213 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2022 | 371 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 202 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2021 | 130 | 0.050 |
Why?
|
| Cell Survival | 1 | 2023 | 983 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2020 | 160 | 0.050 |
Why?
|
| Attitude to Health | 1 | 1982 | 222 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 51 | 0.040 |
Why?
|
| Ataxia | 1 | 2000 | 39 | 0.040 |
Why?
|
| Receptors, Dopamine | 2 | 1994 | 37 | 0.040 |
Why?
|
| Hemodynamics | 1 | 1984 | 731 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2020 | 208 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 1998 | 111 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2020 | 48 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 3666 | 0.040 |
Why?
|
| Reaction Time | 1 | 2021 | 310 | 0.040 |
Why?
|
| Sampling Studies | 2 | 1991 | 72 | 0.040 |
Why?
|
| Reference Values | 3 | 2009 | 661 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1525 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1980 | 274 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1597 | 0.040 |
Why?
|
| Endorphins | 3 | 1985 | 13 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2018 | 8 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 136 | 0.040 |
Why?
|
| Period Circadian Proteins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2018 | 17 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 44 | 0.040 |
Why?
|
| Dairying | 1 | 2018 | 3 | 0.040 |
Why?
|
| Demography | 2 | 1996 | 183 | 0.040 |
Why?
|
| Language | 1 | 2020 | 154 | 0.040 |
Why?
|
| Recombination, Genetic | 5 | 1991 | 445 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2018 | 62 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 110 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 302 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 49 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 371 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 69 | 0.040 |
Why?
|
| Genes, Recessive | 3 | 1986 | 87 | 0.040 |
Why?
|
| Auditory Perception | 1 | 2019 | 97 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2008 | 529 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2021 | 491 | 0.040 |
Why?
|
| Biological Science Disciplines | 1 | 1998 | 12 | 0.040 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 28 | 0.040 |
Why?
|
| Weight Gain | 1 | 2018 | 119 | 0.040 |
Why?
|
| War Crimes | 1 | 1997 | 2 | 0.040 |
Why?
|
| Receptors, Thyrotropin | 1 | 2017 | 47 | 0.040 |
Why?
|
| Women | 1 | 1998 | 25 | 0.040 |
Why?
|
| Sterilization, Reproductive | 1 | 1997 | 12 | 0.040 |
Why?
|
| Germany | 1 | 1997 | 72 | 0.040 |
Why?
|
| Species Specificity | 3 | 2013 | 684 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 124 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1574 | 0.040 |
Why?
|
| Centromere | 2 | 1994 | 26 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1997 | 86 | 0.040 |
Why?
|
| Comorbidity | 4 | 2003 | 949 | 0.040 |
Why?
|
| Body Weight | 1 | 2018 | 452 | 0.040 |
Why?
|
| Algorithms | 2 | 2004 | 1877 | 0.040 |
Why?
|
| Isoproterenol | 2 | 1987 | 62 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 1997 | 19 | 0.040 |
Why?
|
| Multigene Family | 1 | 1997 | 203 | 0.040 |
Why?
|
| Nasal Provocation Tests | 1 | 2017 | 129 | 0.040 |
Why?
|
| Dysthymic Disorder | 1 | 1996 | 4 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 1998 | 169 | 0.030 |
Why?
|
| Forecasting | 1 | 1998 | 306 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 277 | 0.030 |
Why?
|
| Somatostatin | 2 | 1987 | 53 | 0.030 |
Why?
|
| Christianity | 1 | 1996 | 37 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2016 | 9057 | 0.030 |
Why?
|
| Valproic Acid | 1 | 2016 | 24 | 0.030 |
Why?
|
| Chromosome Disorders | 2 | 1986 | 115 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2004 | 1653 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 1996 | 33 | 0.030 |
Why?
|
| Morbidity | 1 | 1996 | 149 | 0.030 |
Why?
|
| Epistasis, Genetic | 2 | 2008 | 90 | 0.030 |
Why?
|
| Criminal Psychology | 1 | 1995 | 2 | 0.030 |
Why?
|
| Norepinephrine | 4 | 1985 | 172 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 135 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1997 | 312 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1996 | 97 | 0.030 |
Why?
|
| Receptors, Melanocortin | 1 | 1995 | 2 | 0.030 |
Why?
|
| Receptors, Adrenergic | 1 | 1995 | 15 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 26 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2016 | 158 | 0.030 |
Why?
|
| Social Adjustment | 4 | 1986 | 47 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 1985 | 155 | 0.030 |
Why?
|
| Diet | 1 | 2018 | 442 | 0.030 |
Why?
|
| Prolactin | 3 | 1984 | 89 | 0.030 |
Why?
|
| Jews | 1 | 1975 | 42 | 0.030 |
Why?
|
| Receptors, Cannabinoid | 2 | 1991 | 5 | 0.030 |
Why?
|
| Clozapine | 1 | 1994 | 9 | 0.030 |
Why?
|
| Growth Hormone | 3 | 1984 | 96 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 1 | 0.030 |
Why?
|
| Individuality | 1 | 1995 | 110 | 0.030 |
Why?
|
| Adenylyl Cyclases | 2 | 1986 | 100 | 0.030 |
Why?
|
| Butyrophilins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Deoxy Sugars | 1 | 1974 | 3 | 0.030 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 1985 | 26 | 0.030 |
Why?
|
| Homovanillic Acid | 2 | 1985 | 35 | 0.030 |
Why?
|
| Social Class | 1 | 1975 | 136 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 2496 | 0.030 |
Why?
|
| Siblings | 1 | 2014 | 111 | 0.030 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 2 | 1985 | 2 | 0.030 |
Why?
|
| Fructose | 1 | 1974 | 36 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2014 | 83 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 275 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 1996 | 988 | 0.030 |
Why?
|
| Tyramine | 2 | 1984 | 4 | 0.030 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 1985 | 18 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1993 | 55 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2008 | 66 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 267 | 0.030 |
Why?
|
| Substance-Related Disorders | 4 | 2003 | 415 | 0.030 |
Why?
|
| ABO Blood-Group System | 2 | 1984 | 58 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1993 | 134 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 2015 | 0.030 |
Why?
|
| Food Preferences | 1 | 2013 | 26 | 0.030 |
Why?
|
| Sodium | 1 | 1974 | 331 | 0.030 |
Why?
|
| Parvalbumins | 1 | 2012 | 7 | 0.030 |
Why?
|
| Tic Disorders | 1 | 1992 | 8 | 0.030 |
Why?
|
| COS Cells | 1 | 2013 | 167 | 0.030 |
Why?
|
| Photic Stimulation | 2 | 2014 | 501 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 466 | 0.030 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 1 | 1992 | 3 | 0.030 |
Why?
|
| Tourette Syndrome | 1 | 1992 | 25 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1652 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 114 | 0.030 |
Why?
|
| Heart Rate | 2 | 1986 | 495 | 0.030 |
Why?
|
| Testis | 1 | 2013 | 152 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1974 | 299 | 0.030 |
Why?
|
| Speech Perception | 1 | 2012 | 71 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2003 | 125 | 0.030 |
Why?
|
| Blood Pressure | 3 | 1986 | 900 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 1992 | 129 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 275 | 0.020 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1991 | 5 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 1243 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 188 | 0.020 |
Why?
|
| Cannabinoids | 1 | 1991 | 12 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 17 | 0.020 |
Why?
|
| Glucose | 1 | 1974 | 630 | 0.020 |
Why?
|
| Selection Bias | 1 | 2011 | 37 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 39 | 0.020 |
Why?
|
| Pseudohypoparathyroidism | 1 | 1990 | 5 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1224 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 269 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 268 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 1990 | 51 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 3783 | 0.020 |
Why?
|
| beta-Endorphin | 3 | 1985 | 11 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 144 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 8241 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 228 | 0.020 |
Why?
|
| Biometry | 2 | 1988 | 66 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1992 | 162 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 41 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 727 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 117 | 0.020 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1989 | 32 | 0.020 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1969 | 11 | 0.020 |
Why?
|
| Neuregulin-1 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 36 | 0.020 |
Why?
|
| Twins, Dizygotic | 2 | 1982 | 40 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2009 | 48 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2011 | 370 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 860 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1974 | 805 | 0.020 |
Why?
|
| Fear | 1 | 2009 | 79 | 0.020 |
Why?
|
| Medical Records | 2 | 1984 | 120 | 0.020 |
Why?
|
| Hospitalization | 6 | 1984 | 877 | 0.020 |
Why?
|
| Bulimia | 1 | 1989 | 141 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2008 | 15 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2008 | 24 | 0.020 |
Why?
|
| Chromosome Fragility | 1 | 1988 | 4 | 0.020 |
Why?
|
| Wnt3 Protein | 1 | 2008 | 14 | 0.020 |
Why?
|
| Chromosome Fragile Sites | 1 | 1988 | 6 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2558 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 1986 | 240 | 0.020 |
Why?
|
| Blood Group Antigens | 2 | 1979 | 17 | 0.020 |
Why?
|
| Animal Testing Alternatives | 1 | 1988 | 1 | 0.020 |
Why?
|
| Seasons | 2 | 1987 | 237 | 0.020 |
Why?
|
| Cyclothymic Disorder | 3 | 1984 | 3 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 781 | 0.020 |
Why?
|
| Hostility | 1 | 1968 | 25 | 0.020 |
Why?
|
| Chromosomes | 2 | 1980 | 97 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 30 | 0.020 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2008 | 6 | 0.020 |
Why?
|
| Birth Order | 1 | 1987 | 7 | 0.020 |
Why?
|
| China | 1 | 2008 | 233 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 543 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2007 | 23 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 2008 | 64 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2008 | 81 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 389 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 1987 | 66 | 0.020 |
Why?
|
| Light | 1 | 1988 | 292 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 1994 | 1719 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 229 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 126 | 0.020 |
Why?
|
| Pindolol | 1 | 1987 | 6 | 0.020 |
Why?
|
| Iodocyanopindolol | 1 | 1987 | 2 | 0.020 |
Why?
|
| Amygdala | 1 | 1988 | 86 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2008 | 234 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 1987 | 32 | 0.020 |
Why?
|
| Haloperidol | 2 | 1984 | 29 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1132 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2013 | 762 | 0.020 |
Why?
|
| Pulse | 2 | 1983 | 17 | 0.020 |
Why?
|
| North America | 1 | 1987 | 184 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1986 | 78 | 0.020 |
Why?
|
| Dihydroergotoxine | 1 | 1986 | 1 | 0.020 |
Why?
|
| Personality Disorders | 3 | 1975 | 145 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 1986 | 145 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1986 | 4 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2006 | 39 | 0.020 |
Why?
|
| Indomethacin | 1 | 2006 | 59 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1157 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 2006 | 33 | 0.020 |
Why?
|
| Granulosa Cells | 1 | 2006 | 32 | 0.020 |
Why?
|
| Psychometrics | 2 | 1996 | 330 | 0.020 |
Why?
|
| beta-Lipotropin | 1 | 1985 | 2 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2006 | 258 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1985 | 13 | 0.020 |
Why?
|
| Anthropometry | 1 | 1986 | 75 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1985 | 103 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 374 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 1986 | 56 | 0.020 |
Why?
|
| Simplexvirus | 1 | 1986 | 151 | 0.020 |
Why?
|
| Atrophy | 1 | 1986 | 120 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 313 | 0.020 |
Why?
|
| Glycols | 3 | 1981 | 8 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1985 | 131 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1985 | 12 | 0.020 |
Why?
|
| Phenylketonurias | 2 | 1979 | 17 | 0.020 |
Why?
|
| Filamins | 1 | 2005 | 22 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 3218 | 0.020 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1984 | 2 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2005 | 57 | 0.020 |
Why?
|
| Hyperphagia | 1 | 1984 | 36 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2004 | 11 | 0.020 |
Why?
|
| Biological Transport | 2 | 1977 | 401 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2004 | 17 | 0.020 |
Why?
|
| Genetics, Population | 1 | 1988 | 406 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 1986 | 465 | 0.010 |
Why?
|
| Child Development | 1 | 1986 | 167 | 0.010 |
Why?
|
| Social Support | 1 | 1986 | 209 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1986 | 698 | 0.010 |
Why?
|
| Catecholamines | 2 | 1983 | 92 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2005 | 144 | 0.010 |
Why?
|
| Hypermedia | 1 | 2004 | 2 | 0.010 |
Why?
|
| Moxisylyte | 1 | 1984 | 1 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2005 | 195 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 1984 | 24 | 0.010 |
Why?
|
| Propranolol | 1 | 1984 | 44 | 0.010 |
Why?
|
| Computers | 1 | 1984 | 112 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 887 | 0.010 |
Why?
|
| Glycopyrrolate | 1 | 1983 | 4 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1985 | 463 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 212 | 0.010 |
Why?
|
| History | 1 | 1983 | 2 | 0.010 |
Why?
|
| History, Modern 1601- | 1 | 1983 | 3 | 0.010 |
Why?
|
| Receptors, Neurotensin | 1 | 1983 | 3 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1983 | 15 | 0.010 |
Why?
|
| Legislation as Topic | 1 | 1983 | 3 | 0.010 |
Why?
|
| Receptors, Angiotensin | 1 | 1983 | 12 | 0.010 |
Why?
|
| Government | 1 | 1983 | 9 | 0.010 |
Why?
|
| Hazardous Substances | 1 | 1983 | 7 | 0.010 |
Why?
|
| Federal Government | 1 | 1983 | 29 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 1983 | 34 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 353 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 1983 | 33 | 0.010 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 1983 | 21 | 0.010 |
Why?
|
| Receptors, Opioid | 1 | 1983 | 23 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1988 | 688 | 0.010 |
Why?
|
| 4-Aminobutyrate Transaminase | 1 | 1982 | 1 | 0.010 |
Why?
|
| Receptors, Somatostatin | 1 | 1983 | 34 | 0.010 |
Why?
|
| Synapses | 1 | 2005 | 280 | 0.010 |
Why?
|
| Receptors, Vasopressin | 1 | 1982 | 7 | 0.010 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1982 | 23 | 0.010 |
Why?
|
| Neurotic Disorders | 2 | 1975 | 13 | 0.010 |
Why?
|
| Transaminases | 1 | 1982 | 33 | 0.010 |
Why?
|
| Citrates | 1 | 1982 | 28 | 0.010 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1982 | 21 | 0.010 |
Why?
|
| Angiotensin II | 1 | 1983 | 93 | 0.010 |
Why?
|
| Politics | 1 | 1983 | 52 | 0.010 |
Why?
|
| Citric Acid | 1 | 1982 | 40 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2003 | 152 | 0.010 |
Why?
|
| Sleep Wake Disorders | 2 | 1980 | 117 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1982 | 6 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1986 | 1150 | 0.010 |
Why?
|
| Research Personnel | 1 | 1983 | 71 | 0.010 |
Why?
|
| Schizophrenia, Disorganized | 1 | 1982 | 2 | 0.010 |
Why?
|
| Schizophrenia, Paranoid | 1 | 1982 | 4 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1983 | 160 | 0.010 |
Why?
|
| Parents | 1 | 1985 | 285 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1982 | 177 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1993 | 6811 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1988 | 2486 | 0.010 |
Why?
|
| Child Rearing | 1 | 1981 | 6 | 0.010 |
Why?
|
| Intellectual Disability | 2 | 1975 | 189 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 1982 | 79 | 0.010 |
Why?
|
| Affect | 1 | 2003 | 387 | 0.010 |
Why?
|
| Transcription Factor 4 | 1 | 2000 | 4 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 2000 | 24 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1982 | 784 | 0.010 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2000 | 29 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2000 | 53 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1982 | 232 | 0.010 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1979 | 7 | 0.010 |
Why?
|
| Disulfiram | 1 | 1979 | 8 | 0.010 |
Why?
|
| Heterozygote | 2 | 1979 | 373 | 0.010 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 1979 | 19 | 0.010 |
Why?
|
| Esterases | 1 | 1979 | 13 | 0.010 |
Why?
|
| Motor Activity | 2 | 1982 | 327 | 0.010 |
Why?
|
| Epinephrine | 2 | 1992 | 88 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1998 | 74 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1997 | 37 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 1998 | 48 | 0.010 |
Why?
|
| Adjustment Disorders | 2 | 1981 | 6 | 0.010 |
Why?
|
| Counseling | 1 | 1979 | 164 | 0.010 |
Why?
|
| Ataxin-1 | 1 | 1996 | 3 | 0.010 |
Why?
|
| Ataxins | 1 | 1996 | 6 | 0.010 |
Why?
|
| Receptors, Dopamine D3 | 1 | 1996 | 18 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1976 | 371 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1976 | 106 | 0.010 |
Why?
|
| Homozygote | 1 | 1996 | 204 | 0.010 |
Why?
|
| Israel | 1 | 1975 | 57 | 0.010 |
Why?
|
| Social Behavior Disorders | 1 | 1975 | 19 | 0.010 |
Why?
|
| Asia | 1 | 1975 | 98 | 0.010 |
Why?
|
| Africa | 1 | 1975 | 101 | 0.010 |
Why?
|
| Emigration and Immigration | 1 | 1975 | 48 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 1994 | 11 | 0.010 |
Why?
|
| Tritium | 1 | 1974 | 133 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1985 | 2661 | 0.010 |
Why?
|
| Placebos | 1 | 1994 | 214 | 0.010 |
Why?
|
| Mannitol | 1 | 1974 | 50 | 0.010 |
Why?
|
| Europe | 1 | 1975 | 321 | 0.010 |
Why?
|
| Genome | 1 | 1997 | 386 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1994 | 389 | 0.010 |
Why?
|
| Cricetinae | 1 | 1974 | 558 | 0.010 |
Why?
|
| Methyltyrosines | 1 | 1972 | 1 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1972 | 13 | 0.010 |
Why?
|
| Amitriptyline | 1 | 1972 | 11 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1980 | 3731 | 0.010 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1972 | 6 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1992 | 120 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1991 | 27 | 0.010 |
Why?
|
| Family Characteristics | 2 | 1983 | 48 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 39 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 177 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1990 | 8 | 0.010 |
Why?
|
| Models, Psychological | 1 | 1971 | 158 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 77 | 0.010 |
Why?
|
| Methyltransferases | 1 | 1971 | 192 | 0.010 |
Why?
|
| Homocystinuria | 1 | 1969 | 2 | 0.010 |
Why?
|
| Hartnup Disease | 1 | 1969 | 2 | 0.010 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1969 | 7 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 1 | 1969 | 23 | 0.010 |
Why?
|
| Massachusetts | 1 | 1969 | 33 | 0.010 |
Why?
|
| Methionine | 1 | 1969 | 65 | 0.010 |
Why?
|
| Tryptophan | 1 | 1969 | 92 | 0.010 |
Why?
|
| Psychoanalytic Theory | 1 | 1968 | 2 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1969 | 306 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1976 | 2366 | 0.000 |
Why?
|
| Psychopathology | 1 | 1968 | 30 | 0.000 |
Why?
|
| Catechols | 3 | 1972 | 9 | 0.000 |
Why?
|
| Feeding and Eating Disorders | 1 | 1989 | 180 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1988 | 98 | 0.000 |
Why?
|
| Viruses | 1 | 1988 | 78 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 2062 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1988 | 268 | 0.000 |
Why?
|
| Internal-External Control | 1 | 1986 | 45 | 0.000 |
Why?
|
| Hypertension | 1 | 1992 | 745 | 0.000 |
Why?
|
| Problem Solving | 1 | 1986 | 54 | 0.000 |
Why?
|
| Self Concept | 1 | 1986 | 133 | 0.000 |
Why?
|
| Rats | 1 | 1992 | 4041 | 0.000 |
Why?
|
| Interpersonal Relations | 1 | 1986 | 175 | 0.000 |
Why?
|
| Connecticut | 1 | 1984 | 26 | 0.000 |
Why?
|
| Social Behavior | 1 | 1986 | 299 | 0.000 |
Why?
|
| Lithium Carbonate | 1 | 1983 | 7 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1984 | 187 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1983 | 672 | 0.000 |
Why?
|
| Phenylalanine | 1 | 1979 | 35 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1982 | 206 | 0.000 |
Why?
|
| Tyrosine | 1 | 1979 | 133 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1979 | 1942 | 0.000 |
Why?
|
| Vanilmandelic Acid | 1 | 1972 | 4 | 0.000 |
Why?
|
| Normetanephrine | 1 | 1972 | 4 | 0.000 |
Why?
|
| Phenylacetates | 1 | 1972 | 3 | 0.000 |
Why?
|
| Chromatography, Gas | 1 | 1972 | 28 | 0.000 |
Why?
|
| Euphoria | 1 | 1972 | 43 | 0.000 |
Why?
|